Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

UPDATE 1-McDonald's to cut global antibiotic use in chickens

Published 2017-08-23, 01:07 p/m
Updated 2017-08-23, 01:10 p/m
UPDATE 1-McDonald's to cut global antibiotic use in chickens

UPDATE 1-McDonald's to cut global antibiotic use in chickens

By Lisa Baertlein

LOS ANGELES, Aug 23 (Reuters) - McDonald's Corp (NYSE:MCD) MCD.N on Wednesday said that it would begin curbing the use of the high value human antibiotics in its global chicken supply in 2018, as the fast-food giant joins a broad effort to battle dangerous superbugs.

McDonald's, in a policy statement, said it is working on antibiotic plans for other meats, dairy cows and laying hens.

McDonald's is requiring suppliers of chicken meat to begin phasing out the use of antibiotics defined by the World Health Organization as "highest priority critically important antimicrobials" (HPCIA) to human medicine.

Public health and consumer groups applauded the move, which is not as strict as the company's policy for the United States, where already for a year suppliers have provided the chain with chickens raised without antibiotics deemed important to human health.

In January 2018, HPCIAs will be gone from McDonald's chickens in Brazil, Canada, Japan, South Korea, the United States and Europe. Only in Europe the company will make an exception for Colistin, a last resort antibiotic.

By the end of 2019, suppliers in Australia and Russia will stop using HPCIAs and European suppliers plan to remove Colistin.

Suppliers in all other markets will comply by January 2027.

"Our goal is to have this policy implemented before this date," McDonald's said in its posted antibiotic policy update.

McDonald's told a group of consumer and environmental organizations on Aug. 17 that 74 percent of its global chicken sales will conform to this policy as of January 2018, Consumers Union, the policy division of Consumer Reports, said in a statement.

Consumers Union also said the company told the group that it hopes to have a timeline soon for reducing medically important antibiotics from its beef supply.

McDonald's declined comment on sales figures and its plans for beef.

More than 70 percent of medically important antibiotics in the United States are sold for livestock use. Scientists have warned routine use of antibiotics to promote growth and prevent illness in healthy farms animals contributes to the rise of dangerous antibiotic-resistant superbug infections, which kill at least 23,000 Americans each year and pose a significant threat to global health.

"If fully implemented, (the plans) could be a total game changer that could transform the marketplace given the company's massive buying power," Jean Halloran, Consumers Union's director of food policy initiatives, said in a statement.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.